Pearls and Prep

There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.”

Patients know the difference. Know the WHY!

Join our clinical library today on PATREON!

👉 https://www.patreon.com/PearlsandPrep

Vraylar vs Abilify: what’s the actual difference—and when would a psychiatric provider choose one over the other?

In this episode of Pearls and Prep, NPZ breaks down cariprazine (Vraylar) vs aripiprazole (Abilify) in a practical, easy-to-remember comparison for psychiatric nurse practitioner students, new grad PMHNPs, and mental health clinicians.

We cover the FDA indications that separate these medications, including schizophrenia, bipolar I disorder, major depressive disorder augmentation, bipolar depression, irritability associated with autism, and Tourette’s disorder. Then we go deeper into the psychopharmacology: D2 vs D3 partial agonism, why Vraylar’s D3 activity matters when thinking about motivation and negative symptoms, and how serotonin receptors fit into the picture.

You’ll also learn why bipolar depression is such an important distinction between these medications, why Abilify’s long-acting injectable formulations can completely change the decision for a patient struggling with adherence, and how akathisia may show up simply as a patient telling you, “This medication is making me incredibly anxious.”

And then there’s the real-world issue that can override everything else: access and cost.

By the end, you’ll have a much clearer framework for thinking through Vraylar vs Abilify—not just memorizing two medication profiles, but understanding how FDA indications, receptors, side effects, adherence, cost, and the patient sitting in front of you all influence the decision.

🎧 Topics include: Vraylar vs Abilify, cariprazine vs aripiprazole, bipolar I depression, bipolar mania, schizophrenia, negative symptoms, D2 and D3 receptors, partial dopamine agonists, MDD augmentation, akathisia, antipsychotic side effects, LAI antipsychotics, autism irritability, and psychopharmacology for PMHNP students.

Want the full teaching library + my 100 Psychiatric Interview Tips eBook? Join Boss Pearl at Patreon.com/PearlsAndPrep.

Educational content only. This podcast does not provide individualized medical advice.

35

Vraylar vs Abilify: What’s the Actual Difference? D2, D3 & Beyond

Pearls and Prep

[email protected]

https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink

There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.”

Patients know the difference. Know the WHY!

Join our clinical library today on PATREON!

👉 https://www.patreon.com/PearlsandPrep

A patient has panic attacks, avoids driving, and recently witnessed a traumatic accident. PTSD seems obvious—but is it?

In this psychiatric case study, we break down panic disorder vs PTSD and explore why these diagnoses can look remarkably similar in clinical practice. You’ll learn how to distinguish trauma-related avoidance from fear of another panic attack, identify what the patient’s intrusive experiences are actually about, and uncover the “center of gravity” of the patient’s distress.

Perfect for PMHNP students, psychiatric nurse practitioners, psychiatry students, and mental health clinicians, this episode offers practical interviewing pearls for navigating ambiguous presentations without being led astray by a dramatic trauma history.

Pearls covered: panic disorder, panic attacks, PTSD, trauma, avoidance, intrusive symptoms, differential diagnosis, DSM-5-TR reasoning, psychiatric assessment, and high-yield clinical interviewing.

34

Panic Disorder vs PTSD: How to Tell the Difference

Pearls and Prep

[email protected]

https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink

There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.”

Patients know the difference. Know the WHY!

Join our clinical library today on PATREON!

👉 https://www.patreon.com/PearlsandPrep

Schizoid or Schizotypal? They Look Alike—Until You Ask WHY

Schizoid and schizotypal personality disorder sound alike—and both patients may appear socially isolated, detached, or eccentric—but the reason WHY they withdraw can be completely different.

In this episode of Pearls and Prep, NPZ breaks down schizoid vs schizotypal personality disorder using practical outpatient clues: what these patients may actually say in your office, why they avoid relationships, how their social histories differ, and what to listen for when exploring suspiciousness, ideas of reference, magical thinking, unusual beliefs, and restricted affect.

We also tackle the differentials that can trip clinicians up: schizophrenia and psychosis, autism spectrum disorder, depression, social anxiety, and avoidant personality disorder.

The big pearl: don't just notice that your patient is isolated—figure out WHY they're isolated. That distinction can completely change your diagnostic formulation.

🎧 Your preceptor in your pocket: practical psychiatric pearls that prep you to practice.

33

Schizoid or Schizotypal? The Clinical Clues That Give It Away

Pearls and Prep

[email protected]

https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink

There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.”

Patients know the difference. Know the WHY!

Join our clinical library today on PATREON!

👉 https://www.patreon.com/PearlsandPrep

Why I Have a Love-Hate Relationship with Latuda

Latuda (lurasidone) is one of the most unique medications in psychiatry—but it's also one of the easiest to misunderstand.

In this episode of Pearls & Prep, we break down exactly when Latuda shines, where it falls short, and how experienced clinicians think through prescribing it in real practice.

You'll learn:

• Why Latuda is FDA-approved for bipolar I depression and schizophrenia

• Why it treats depression but isn't your best option for mania prevention

• How Latuda compares with Seroquel, Abilify, Lamictal, lithium, and Symbyax

• The importance of treating both poles of bipolar disorder—not just today's symptoms

• The famous 350-calorie food requirement and why it matters clinically

• Why Latuda is considered one of the more weight-neutral antipsychotics

• Common adverse effects including akathisia, nausea, and movement disorders

• Practical prescribing pearls you'll actually remember during patient care

Whether you're a PMHNP student, psychiatric NP, psychiatry resident, physician assistant, medical student, or practicing clinician, this episode focuses on the clinical reasoning behind medication selection—not just memorizing facts.

If you're preparing for boards or simply want to become more confident prescribing psychiatric medications, this episode is packed with practical psychopharmacology pearls.

32

Why I Have a Love-Hate Relationship with Latuda

Pearls and Prep

[email protected]

https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink

There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.”

Patients know the difference. Know the WHY!

Join our clinical library today on PATREON!

👉 https://www.patreon.com/PearlsandPrep

We’re diving deep into the showdown of the century: Cymbalta vs. Effexor! This isn’t just another med comparison; we’re talking about the nitty-gritty of which one might actually be a better fit for your patients based on their unique circumstances. Just like the classic debates over LeBron vs. MJ, or Yankees vs. Red Sox, it’s all about context here. If you've got a patient battling chronic pain, Cymbalta is often the MVP, but throw in social anxiety and Effexor might steal the spotlight. We’ll break down the ins and outs of these meds, so you can have the knowledge to back up your prescribing game and make your patients feel empowered. Trust me, this is the kind of talk that'll level up your clinical skills!

31

Inside the Ring 🥊: Effexor or Cymbalta? Here’s the Real Difference

Pearls and Prep

[email protected]

https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink

Diving into the juicy details of Cymbalta versus Effexor, we tackle the age-old debate of which med comes out on top. It’s not just about who wears the crown; it’s about the context, baby! Our chat kicks off with a rundown of each medication’s strengths. If your patient is wrestling with chronic pain, Cymbalta is like a heavyweight champ, knocking out discomfort in conditions like fibromyalgia and diabetic neuropathy.

But wait—if social anxiety or panic is more their jam, Effexor might take the lead with its FDA approval for those specific issues. Just like comparing LeBron to MJ, it’s all about the situation at hand! We explore the nitty-gritty of psychopharmacology, empowering folks to make informed decisions when prescribing. As we roll along, we get into the weeds of how these meds actually work. The conversation takes a turn towards the complexities of FDA approvals and manufacturer motivations. It turns out, Cymbalta was all about pain trials, while Effexor was strutting its stuff in the anxiety arena. But here’s the kicker: just because Cymbalta isn’t FDA-approved for social anxiety doesn’t mean it’s a slouch in that department.

We’re here to remind you that real-life practice doesn’t always align with textbook rules. Every patient is a unique puzzle, and understanding their pain versus anxiety levels can make all the difference in choosing the right med. Wrapping it up, we emphasize the importance of patient context and the subtleties that can sway a prescribing decision. We touch on the potential for side effects, protein binding quirks, and the unpredictable nature of drug interactions. It’s a rollercoaster of insights that leaves us with a reminder: there’s no one-size-fits-all answer—just like in life, it’s about finding what fits best for each individual. Tune in for a smart and sassy breakdown of the meds that can change lives!

Takeaways:

• Cymbalta is a solid choice for patients with chronic pain, like fibromyalgia, while Effexor shines brighter for anxiety disorders.
• Understanding the context of a patient's condition is crucial when choosing between Cymbalta and Effexor; it's not one-size-fits-all.
• Both Cymbalta and Effexor have unique properties that make them effective, but their indications can vary based on individual patient needs.
• Medication interactions are a big deal; if your patient is on multiple drugs, keeping an eye on protein binding is super important for safety.

Companies mentioned in this episode:

• Cymbalta
• Effexor

There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.”

Patients know the difference. Know the WHY!

Join our clinical library today on PATREON!

👉 https://www.patreon.com/PearlsandPrep

Want to feel more confident interviewing psychiatric patients? In this episode of Pearls and Prep, NPZ shares 4 psychiatric interview skills every new PMHNP needs to conduct smoother, more organized, and more human psychiatric evaluations.

Learn how to use a structured psychiatric intake, build genuine therapeutic rapport, recognize important clinical clues, ask better follow-up questions, and develop a repeatable system that keeps your evaluation on track.

You’ll also learn two memorable interviewing techniques: the “life raft” approach for helping patients feel genuinely heard and the “squeeze the orange” technique for recognizing and exploring the valuable diagnostic clues patients drop during their stories.

Whether you're a PMHNP student, new psychiatric nurse practitioner, or new mental health provider, these practical psychiatric evaluation tips will help you ask better questions, improve your clinical interviewing skills, and walk into your next patient encounter with more confidence.

🎧 Pearls and Prep: Your preceptor in your pocket.

Topics: psychiatric interview skills, psychiatric evaluation, PMHNP, PMHNP student, psychiatric assessment, mental health assessment, psychiatric intake, new grad PMHNP, clinical interviewing, therapeutic rapport

34

How to Interview Psychiatric Patients With Confidence: 4 Skills Every New PMHNP Needs

Pearls and Prep

[email protected]

https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink

There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.”

Patients know the difference. Know the WHY!

Join our clinical library today on PATREON!

👉 https://www.patreon.com/PearlsandPrep

Today, we're diving into the world of long-acting injectable medications—LAIs for short. These bad boys are a game-changer in psychiatry, offering some serious perks. We’ll chat about how they bypass the messy first-pass metabolism of oral meds, making them more reliable and predictable for patients. I mean, who doesn’t want fewer side effects and more consistent plasma levels? Plus, we’ll explore how LAIs help keep patients engaged with their healthcare, which is a win-win for everyone involved. So grab a comfy seat and let’s get into the nitty-gritty of why LAIs might just be the secret sauce to better patient outcomes!

30

Why LAIs Are the Real MVPs in Psychiatry

Pearls and Prep

[email protected]

https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink

We dove deep into the world of long-acting injectables (LAIs) today, and let me tell you, it was a wild ride! Think of LAIs as the cool cousins of your everyday oral meds. Instead of popping pills every day like a game of medication whack-a-mole, these bad boys are injected and can last for weeks—talk about convenience! We chatted about how LAIs can bypass the dreaded first-pass metabolism (yawn, I know) and go straight into the bloodstream, making them more reliable. This means fewer side effects and a smoother ride for our patients. Plus, we covered the magic of “flip-flop pharmacokinetics”—no, that’s not a new dance move! It’s all about how LAIs slowly release their medication, giving patients a steady dose without those dramatic peaks and troughs that oral meds can cause. So, if you’ve got patients who struggle with taking their meds regularly, LAIs might just be the superhero they need.

Takeaways:

• Long acting injectables (LAIs) offer a reliable way to bypass hepatic metabolism for better drug absorption.
• When prescribing LAIs, you reduce the variability of medication effects across different patients, which can simplify treatment.
• LAIs can help create regular healthcare interactions, leading to better overall management of patient health and adherence to other medications.
• Understanding the pharmacokinetics of LAIs is crucial, as they provide a steadier plasma level compared to oral meds.
• Adherence is a huge problem in medication management, and LAIs can significantly improve patient compliance.
• Using LAIs proactively can prevent relapses rather than reactively responding after issues arise.

Companies mentioned in this episode:

• Zyprexa
• Abilify
• Lexapro
• Prozac
• Paxil
• Latuda
• Invega

There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.”

Be the second on Patreon:

👉 https://www.patreon.com/PearlsandPrep

Today, we're diving into the wild world of false positive drug screens and how they can throw a wrench in a patient's treatment plan. We’ll share Jimmy's story, a (mock patient) guy whose life took a serious detour because of miscommunication and medication mishaps. He was on a roll—getting his life together, taking care of his daughter, and then boom! A positive drug screen for benzodiazepines, even though he wasn’t taking any. Turns out, the meds he was prescribed can cause these false positives, and nobody connected those dots. We’ll unpack this mess and chat about how crucial it is to communicate in the medical field, so we can avoid putting patients in hot water when they’re just trying to do their best. Stick around for some pearls of wisdom that might just help keep our patients safe and sound!

29

Drug Tests Aren’t Always Right—Here’s Where Things Go Wrong

Pearls and Prep

[email protected]

https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink

Let’s dive into the messy world of drug screens, shall we? We kick things off with our buddy Jimmy, a 34-year-old insurance salesman who’s been keeping his life in check with some serious help from his opioid treatment program. He’s been doing great—negative drug tests for a whole year, even got to take home his meds like a champ! But then, bam! His psychiatrist throws some new meds into the mix without a heads-up to his treatment team, and suddenly Jimmy’s life spirals into chaos. We break down how a couple of common prescriptions can mess with drug tests, leading to false positives that can ruin lives. Our convo flows from the nitty-gritty of communication breakdowns in healthcare to the real-life implications for patients like Jimmy. Spoiler alert: it’s a wild ride that shows how easy it is to misinterpret a drug test and the devastating consequences that can follow. Buckle up!

Takeaways:

• In this episode, we dived deep into how false positive drug screens can really mess with treatment plans, especially in the world of psychiatry.
• We shared a wild case about Jimmy, whose meds led to a false positive for benzos, causing him to lose take-home privileges – talk about a bummer!
• Communication is key, folks! Jimmy's story shows how a lack of info between doctors can lead to major misunderstandings and hurt patients' progress.
• Turns out, meds like Zoloft and Trazodone can trigger false positives for benzodiazepines, which is just one reason we need to be on our game with prescribing.
• We need to advocate for confirmatory testing – don’t let false positives ruin your life or your treatment plan, people!
• Overall, the episode was all about ensuring we understand the meds we prescribe and how they can impact our patients' lives in unexpected ways.

Companies mentioned in this episode:

• Sertraline
• Trazodone
• Quetiapine
• Seroquel
• Dairy Queen
• Abilify
• Effexor
• Wellbutrin

There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.”

Be the second on Patreon:

👉 https://www.patreon.com/PearlsandPrep

We’re diving into a juicy case study today, featuring our mock patient, Debbie, and her whirlwind of symptoms that might have you guessing whether she’s dealing with ADHD or bipolar disorder. The big takeaway? These two can look a whole lot alike, and getting it wrong can lead to some serious consequences, like triggering a manic episode when all you wanted to do was help. We’ll chat about how important it is to ask the right questions and dig deep into a patient’s history to figure out what’s really going on. Plus, we’ll share some pearls of wisdom on how to tease apart these diagnoses, because not everything in the mental health world comes neatly packaged. So, buckle up as we sort through Debbie's story and uncover what it all means!

28

ADHD or Bipolar? The Questions That Actually Reveal the Truth

Pearls and Prep

[email protected]

https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink

Debbie shows up to the clinic with what looks like a classic case of indecisiveness mixed with a sprinkle of chaos. She’s got a history that sounds like a sitcom episode—projects started and abandoned like they were hot potatoes. Whether she’s just got a wild case of ADHD or if there’s something more sinister, like bipolar lurking behind her cheerful facade, is the million-dollar question. As we peel back the layers of her story, we learn about her impulsive spending habits, job losses, and some familial ties to mental health issues that make us raise an eyebrow. The show dives deep into the importance of distinguishing between ADHD and bipolar disorder, emphasizing that missteps in diagnosis can lead to significant treatment blunders. If we slap an Adderall label on her without figuring out the bipolar puzzle, we might just send her spiraling into a manic episode. It's a wild ride of clinical insights and personal anecdotes, all while we figure out the nuances of mental health diagnoses that can be as tricky as untangling earbuds.

Takeaways:

• Understanding the overlap between ADHD and bipolar disorder is crucial for accurate diagnosis and treatment.
• Debbie's impulsive spending and project abandonment raise concerns about potential manic episodes.
• Sleep patterns can be a key indicator in differentiating between ADHD and bipolar disorder symptoms.
• Getting collateral history from family or friends can help clarify a patient's condition and behavior patterns.
• Exploring a patient's work history can reveal patterns that indicate either ADHD or bipolarity.
• Recognizing the timing of symptom onset is essential in distinguishing between ADHD and bipolar disorder.

There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.”

Patients know the difference. Know the WHY!

Join our clinical library today on PATREON!

👉 https://www.patreon.com/PearlsandPrep

What do you do when your psychiatric patient is depressed, anxious, traumatized—or struggling with ADHD—and also tells you they can’t sleep?

This is one of the most common clinical dilemmas new psychiatric nurse practitioners and PMHNP students encounter. Your patient needs treatment for depression or anxiety, but you know an SSRI or SNRI may initially feel activating. They’re already exhausted. They want to sleep tonight. So do you add trazodone? Choose mirtazapine? Try low-dose doxepin or ramelteon? Start the SSRI and wait? Or are you treating the wrong problem entirely?

In this episode of Pearls and Prep, NPZ breaks down a more methodical way to think about insomnia in psychiatric practice: before treating sleeplessness, figure out what is actually keeping the patient awake.

Insomnia is incredibly transdiagnostic. A patient with major depressive disorder may lie awake ruminating about the past, guilt, worthlessness, or perceived failures. A patient with an anxiety disorder may be forecasting everything that could go wrong tomorrow. PTSD may produce hyperarousal, hypervigilance, nightmares, and a nervous system that never seems to feel safe enough to shut down. ADHD can create a different nighttime experience altogether—unfinished tasks, forgotten emails, executive dysfunction, and the feeling that the brain simply won’t turn off.

Those differences matter because they can change your treatment strategy.

We discuss why successfully treating the underlying psychiatric disorder with an SSRI or SNRI can sometimes improve sleep without the medication itself being sedating. We also explore situations where mirtazapine (Remeron) may give you multiple therapeutic advantages at once—particularly when depression or anxiety occurs alongside insomnia and poor appetite—and why duloxetine (Cymbalta) may deserve consideration when pain is one of the major reasons your patient cannot sleep.

Then we tackle the harder question: what if treating the underlying condition isn’t enough?

We walk through CBT-I and why cognitive behavioral therapy for insomnia needs to remain part of the conversation, while also acknowledging the real-world barriers psychiatric clinicians encounter when patients cannot access it, cannot afford it, don’t have time for it, or simply want relief now.

From there, we examine the medication toolbox clinicians commonly encounter, including mirtazapine, trazodone, low-dose doxepin, ramelteon, melatonin, Z-drugs, and newer insomnia treatments. More importantly, we focus on the clinical reasoning behind reaching—or not reaching—for another medication.

Because “this drug is sedating” is not a diagnosis.

We also zoom out to the differential diagnosis. Could nighttime racing thoughts actually represent bipolar disorder? Could the patient have obstructive sleep apnea, restless legs, excessive caffeine intake, medication-induced activation, hyperthyroidism, pain, PTSD-related hyperarousal, or another contributor that you’ll completely miss if you simply prescribe something to knock them out?

This episode is designed for PMHNP students, psychiatric nurse practitioners, new psychiatric prescribers, and clinicians who want to become more deliberate about treating insomnia alongside depression, anxiety, PTSD, ADHD, and other psychiatric conditions.

The goal isn’t to memorize another list of sleep medications.

It’s to become the clinician who can answer the more important question:

Why can’t this particular patient sleep—and what treatment actually matches that reason?

🎧 Pearls and Prep — unforgettable psychiatry pearls for PMHNP students and psychiatric clinicians who want to understand the WHY behind their prescribing.

Want to go deeper? Join Pearls and Prep on Patreon for psychiatric visuals, psychopharmacology deep dives, clinical reasoning resources, and Mafia Pearl™, where I become your mock patient so you can practice interviewing, diagnosis, and treatment decisions before they matter in the real clinical encounter.

33

The Insomnia Trap: Stop Treating Every Sleepless Psychiatric Patient the Same

Pearls and Prep

[email protected]

https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink